Studies mechanisms that regulate neuroinflammation in Alzheimer's disease, stroke, and other neurological disorders. Combines cellular and animal models with transcriptomics, proteomics, systems pharmacology, and high-content screening to identify microglial states, biomarkers, and therapeutic targets such as Kv1.3.